Study: Oral THC Safe And Effective At Treating Symptoms Of Anorexia

"The impact of delta-9-THC on the psychological symptoms of anorexia nervosa: A pilot study," appears in The Israeli Journal of Psychiatry and Related Sciences.

ISRAEL:  The daily administration of low doses of oral THC is associated with treating various symptoms associated with anorexia nervosa, according to clinical trial data published in The Israeli Journal of Psychiatry and Related Sciences. Investigators with Hebrew University in Jerusalem and the Eating Disorders Institution at the University of Haifa assessed the daily use of up to Read the full article…

Study: CBD Therapy Improves Autistic Symptoms

CBD is a major part of the growing legal cannabis market

ISRAEL: The adjunctive use of high CBD oral extracts is associated with improvements in symptom management in children with autism-related behavioral issues, according to clinical data published online ahead of print in the journal Neurology. Israeli researchers assessed the use of oral extracts containing a 20 to 1 ratio of CBD to THC in 60 adolescents with autism spectrum Read the full article…

Patients Dramatically Reduce Their Opioid Use Following Cannabis Access

MMJ reduces opioid use

CANADA: Pain patients enrolled in Canada’s legal medical cannabis access program significantly reduce their use of opioids over the long-term, according to longitudinal data provided by Tilray Canada Ltd - one of the nation’s largest, licensed provider of medicinal marijuana products. Investigators assessed opioid use patterns in a cohort of 573 patients using Tilray-provided products. Among those patients who acknowledged Read the full article…

Study: CBD Extracts Significantly Reduced Seizure Frequency In Children With Refractory Epilepsy

Israeli researchers assessed the sustained daily use of extracted CBD oils in a cohort of young patients with treatment resistant epilepsy.

ISRAEL: The adjunctive use of CBD extracts is safe and effective in adolescent patients with refractory epilepsy, according to clinical data published online ahead of print in the journal Brain & Development. Israeli researchers assessed the sustained daily use of extracted CBD oils in a cohort of young patients with treatment resistant epilepsy. Thirty-five percent of participants experienced a Read the full article…

Patients Use Fewer Opioids Following Enrollment In Medical Cannabis Program

The study's findings are similar to those reported among enrollees in other states' medical cannabis programs, including the experiences of patients in Illinois, Michigan, Minnesota, New Mexico, and elsewhere.

NEW YORK:  Patients enrolled in New York state’s medical cannabis program reduce their use of opioids and spend less money on prescription medications, according to data published online in the journal Mental Health Clinician. Investigators from GPI Clinical Research labs in Rochester and the University of Buffalo assessed trends in patients’ medical cannabis and prescription drug use following Read the full article…

Study: Cannabis Use Associated With Lower Risk Of Atrial Fibrillation Among Patients Hospitalized For Heart Failure

Cannabis Use Associated With Lower Risk Of Atrial Fibrillation Among Patients Hospitalized For Heart Failure

NEW YORK: Cannabis exposure is associated with lower instances of atrial fibrillation (arrhythmia) in patients hospitalized for heart failure, according to data published in the American Journal of Cardiology. A team of investigators from Seton Hall University, the University of Alabama at Birmingham, and elsewhere assessed the relationship between cannabis exposure and atrial fibrillation in a cohort of nearly four million Read the full article…

Alternative Health CEO Updates Shareholders On Spinoff Plans

Management has received Board approval to explore a spinoff plan for the Company’s non-cannabis assets,

TEXAS: The CEO of Alternate Health CEO this week provided further details about the company’s spinoff plans and key milestones for the upcoming quarters. “The Company has been very active this year adjusting our business for revenue generation and growth, including developing our potential spinoff plan for Alternate Health’s non-cannabis assets,” says Dr. Michael Murphy, Chairman and Read the full article…

Court Rejects Challenge To DEA’s Classification Of Marijuana Extracts

Court Rejects Challenge To DEA's Classification Of Marijuana Extracts

CALIFORNIA: A three judge panel for the Ninth Circuit Court of Appeals has denied a petition filed by the Hemp Industries Association challenging the DEA’s authority to establish a new administrative drug code specifically for marijuana extracts. The DEA first announced the proposed rule change in 2011, but did not enact the new policy until January 13, 2017. In a Read the full article…

Oregon’s Medical Marijuana Growers Prepare for Tracking

OLCC news

OHA & OLCC Holding Information Sessions across the State OREGON:  This summer approximately 2,000 medical marijuana growers will need to start using Oregon’s Cannabis Tracking System (CTS) to ensure the marijuana they grow for patients is tracked and reported.  This week the Oregon Health Authority (OHA) and the Oregon Liquor Control Commission (OLCC) launched a series Read the full article…

Tilray Shares Preliminary Data From The Largest National Longitudinal Medical Cannabis Patient Study in Canada

Study finds significant reduction in opioid use and improvements in quality of life within first 6 months.

CANADA: Tilray Canada Ltd., a medical cannabis leader committed to advancing scientific knowledge of cannabinoids, shared preliminary data today from the Tilray Observational Patient Study (TOPS), a Tilray-sponsored survey of medical cannabis patients using Tilray products currently underway at 18 different medical clinics in five provinces in Canada. As Canada’s largest national medical cannabis longitudinal study, Read the full article…